key: cord-0257151-20gmhg12
authors: Pal, Debjani; De, Kuntal; Yates, Timothy B.; Muchero, Wellington
title: Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization
date: 2021-10-12
journal: bioRxiv
DOI: 10.1101/2021.10.11.463689
sha: b2d0b2f326610d8dd21104f876c8142c0a63317d
doc_id: 257151
cord_uid: 20gmhg12

The global pandemic of Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has become a severe global health problem because of its rapid spread(1). Both angiotensin-converting enzyme 2 and neuropilin 1 provide initial viral binding sites for SARS-CoV-2 (2, 3). Here, we show that three cysteine residues located in a1/a2 and b1 domains of neuropilin 1 are necessary for SARS-CoV-2 spike protein internalization in human cells. Mutating cysteines C82, C104 and C147 altered neuropilin 1 stability and binding ability as well as cellular internalization and lysosomal translocation of the spike protein. This resulted in up to 4 times reduction in spike protein load in cells for the original, alpha and delta SARS-CoV-2 variants even in the presence of the endogenous angiotensin-converting enzyme 2 receptor. Transcriptome analysis of cells transfected with mutated NRP1 revealed significantly reduced expression of genes involved in viral infection and replication, including eight members of the ribosomal protein L, ten members of ribosomal protein S and five members of the proteasome β subunit family proteins. We also observed higher expression of genes involved in suppression of inflammation and endoplasmic reticulum associated degradation. These observations suggest that these cysteines offer viable targets for therapies against COVID-19.

in cells co-transfected with HA-NRP1-C82A, C104A and HA-NRP1-4Cys-4Ala mutants 134 compared to wild type NRP1 ( Fig. 2d and Fig. 2e) . 135 136 We also tested whether these cysteines facilitated binding of NRP1 with the co-receptor Plexin-137 A1 as Plexin-A1 helps to form a functional receptor for semaphorin 3A by directly interacting with 138 NRP1(22). HA-NRP1-WT and HA-NRP1-4Cys-4Ala variants were co-expressed with Plexin-A1 in HEK293T cells, and complexes were immunoprecipitated using anti-Flag. Our 140 results indicated that the 4Cys-4Ala mutant was unable to associate with Plexin-A1 ( Fig. S1a and 141 S1b). In agreement with our biochemical data, we reconfirmed that mutating these cysteine 142 residues reduced the colocalization signal for NRP1 and Plexin-A1 when transfected in HeLa cells 143 (Fig. S1c) . 144 145 We then examined whether full-length SARS-CoV-2-S protein could influence the interaction with 146 NRP1. Fig. 3a shows that full-length SARS-CoV-2-S protein is equally susceptible to NRP1 147 cysteine mutations. The interaction between HA-NRP1-4Cys-4Ala and SARS-CoV-2-S was 148 significantly impaired (Fig. 3b) . The immediate development of a vaccine against COVID-19 has 149 provided a vital tool to fight against the rapid spread of the SARS-CoV-2 virus. However, 150 constantly evolving mutations in the S protein imposes a challenge for effective deployment of 151 vaccines. 152

To establish NRP1 as a potential universal candidate for targeted therapy, we used full-length tagged SARS-CoV-2-S, SARS-CoV-2-B.1.1.7-S and 155 representing the original, alpha and beta variants, respectively and used those for colocalization 8 assays. HA-NRP1-4Cys-4Ala was equally incapable of interacting with the variants, as confirmed 157 from the immunofluorescence data (Fig. 3c , e, and g). Additionally, viral spike protein load in cells 158 was reduced significantly (Fig. 3d, f, and h) . This study provides the first experimental evidence 159 supporting our hypothesis that targeting these four specific amino acids in NRP1 could be effective 160 in reducing viral spread irrespective of the spike protein variants, although emerging variants will 161 need to be evaluated. 162 163 SARS-CoV-2 follow the conventional endosomal secretory route for its subsequent maturation 164 and release from the infected cells(23). However, Ghosh et al. recently described that mouse 165 hepatitis virus (MHV, member of β-coronavirus family like SARS-CoV-2) use lysosomal Arl8b-166 dependent pathway for the egress(24). Late endosomes/lysosome deacidification inhibits 167 lysosomal proteases and favor the egress(24). We investigated whether transfected SARS-CoV-2 168 spike protein showed any difference in lysosomal association when co-expressed with 4Cys-4Ala 169 mutant NRP1 in cells. We transfected HeLa cells with Flag tagged SARS-CoV-2 S and HA tagged 170 WT and 4Cys-4Ala NRP1s then co-stained with Flag and the late endosomal/lysosomal 171 transmembrane protein LAMP1 (Fig. S2) . Interestingly, there was significant reduction in the 172 LAMP1 association of spike protein when transfected with NRP1-4Cys-4Ala and observed under 173 confocal microscopy. 174

To ascertain that our observations were related to lower spike protein density in cells, we co-176 transfected HA-NRP1-WT and NRP1-4Cys-4Ala mutant with Flag-SARS-CoV-2-S1 493-685 at 177 different ratios and measured protein levels (Fig. 4a) . Quantification from 3 biological replicates 178 further supported our previous observation that reduced spike protein density was solely due to the 9 lack of functional NRP1 receptor in cells (Fig. 4b) . In fact, increasing the transfection ratio for 180

Flag-SARS-CoV-2-S1 493-685 could not fully rescue the spike protein yield in cells transfected with 181 HA-NRP1-4Cys-4Ala mutant ( Fig. 4a and 4b) . Full-length SARS-CoV-2-S protein also exhibited 182 reduced spike protein density when co-transfected in a 1:1 ratio together with the HA-NRP1-4Cys-183 4Ala mutant compared to wild type (Fig.  4c) . 184 185 An important strategy to fight against viral infections is to identify endogenous host factors used 186 by viral machinery for fostering their infection and replication. One way to address this question 187 is to assess transcriptional responses of cell in response to infection. To that end, we characterized 188 transcriptional responses in cells co-transfected either with HA-NRP1-WT and Flag-SARS-CoV-189 2-S1 493-685 or HA-NRP1-4Cys-4Ala and Flag-SARS-CoV-2-S1 493-685 . Total RNA was extracted 190 from HEK293T cells 30 hrs post-transfection. Transcriptional profiling captured significantly 191 altered expression for several viral-infection marker genes (Fig. S3a) . Specifically, we observed 192 reduced expression for multiple ribosomal proteins in cells transfected with HA- A majority of these are known to play critical role in the life cycle of viruses by promoting viral 194 infection(25) . For instance, it has been reported that RPL3 mutation leads to rapid loss of the M1 195 virus(26) . We also observed reduced expression of RPL13 in cells transfected with mutated HA-196 NRP1-4Cys-4Ala. RPL13 overexpression promotes the induction and activation of promoters for 197 the nuclear factor-κB (NF-κB) and interferon-β (IFN-β) genes(27). The NF-κB pathway is already 198 considered a potential therapeutic target to treat COVID-19 disease(28). Ribosomal proteins 199 RPLP1 and RPLP2 (RPLP1/2) are among the most crucial putative host factors required for the 200 progression of dengue viruses (DENV), yellow fever virus (YFV), and Zika virus (ZIKV) 201 infection(29). Therefore, reduced expression of these might be important in diminishing SARS-202

CoV-2 infection. RPS9(30), and RPLP1/2 are also required for viral protein synthesis(29). Human 203 immunodeficiency virus type 1 (HIV-1) Tat, an essential regulator of viral transcription, inhibits 204 cell proliferation through its interaction with RPS3, which also exhibited significantly reduced 205 expression in our experiment(31). Interestingly, TGFB1-Induced Anti-Apoptotic Factor 1 (TIAF1) 206 had reduced expression in cells transfected with HA-NRP1-4Cys-4Ala and has been previously 207 shown to be involved in HPV16 infection(32). Another notable gene with reduced expression was 208 DNAJB1/HSP40 cellular heat shock protein 40 (Hsp40/DnaJB1) which facilitates nuclear import 209 of incoming influenza A virus (IAV) viral ribonucleoproteins (vRNPs) and is vital for efficient 210 IAV replication(33). Human cytomegalovirus and host Transforming Acidic Coiled-Coil 211

Containing Protein (TACC3) controls the spreading of infection in host cells(34). TACC3 had 212 reduced expression in this study as well. Cumulatively, the reduced expression of genes known to 213 be involved in viral infection and replication is consistent with results presented above. This 214 supports our conclusion that these cysteine residues are essential for SARS-CoV-2 infection. 215 216 Additionally, we evaluated expression patterns of genes that participate in cancer pathways in our 217 transcriptome analysis since cancer patients have significantly increased risk from COVID-19 218 infection(35). Overexpression of NRP1 has been shown to increase tumor growth, invasiveness 219 and is associated with poor prognosis in tumors from the gastrointestinal (GI) tract, prostate, lung, 220 ovary, as well as gliomas, osteosarcomas and melanomas(36-39). The use of NRP1 antagonists 221 are well known in cancer therapy(40). Besides finding decreased expression of genes involved in 222 viral replication, we found considerably low expression of some cancer markers in cells transfected 223 with HA-NRP1-4Cys-4Ala compared to the cells transfected with HA-NRP1-WT in the presence 224 of SARS-CoV-2-S1 493-685 (Fig. S3a) . These included kinesin family member 20A (KIF20A), SRY-225 box 2 (SOX2) and proteasome subunit beta type proteins (PSMB 3/4/5/6/7). KIF20A, which was 226 initially discovered as a key protein in mitosis, was later found to be responsible for poor prognosis 227 in cancers when it is upregulated(11). SOX2 is a universal cancer stem cell marker, accountable 228 for the maintenance of cancer stem cells and tissue homeostasis(41), while PSMB3, 4, and 5 are 229 cancer markers for glioma(42). Growth of lung cancer has been reported to be inhibited by 230 targeting PSMB6(43). PSMB7 is a prognostic biomarker for breast cancer(44). 231 232 On the other hand, transcriptome profiling revealed upregulated expression of several genes 233 implicated in cellular pathways like ubiquitination, degradation and suppression of inflammation. 234

We observed significantly higher expression of both Degradation in ER protein 3 (DERL3) and 235

Homocysteine inducible ER protein with ubiquitin like domain 1 (HERPUD1), both of which are 236 known to promote degradation of misfolded proteins in the endoplasmic reticulum (ER) (45, 46) . 237

Interestingly, DERL3 and has been identified as a potential candidate gene that might be regulated 238 via SARS-CoV-2 induced DNA methylation changes COVID-19 infection(47). HERPUD1 which 239 usually activates innate immune response, is an ER stress marker and was found to be upregulated 240 in L cells infected with mouse hepatitis virus (MHV) or SARS-CoV(48). To our surprise, we saw 241 higher endoplasmic reticulum oxidoreductase 1 beta (ERO1B) expression in cells transfected with 242 HA-NRP1-4Cys-4Ala. ERO1B re-oxidizes PDIA4 leading to reactive oxygen species 243 production(49). Inflammatory responses define the outcome of viral infection and 244 hyperinflammation in COVID-19 contributes to disease severity(50). One of the important factors 245 that play a central role in the initiation and resolution of this response is the NF-κB/REL family of 246 transcription factors. NF-κB subunit c-Rel acts as a transcriptional repressor of inflammatory 247 genes(51). Our results indicated higher expression for both c-REL and NF-κB1 with HA-NRP1-248 4Cys-4Ala in the presence of SARS-CoV-S1 493-685 . 249 250 Finally, figure. S3b shows overlap of genes found to be differentially expressed when cells were 251 transfected with NRP1-WT vs. NRP1-4Cys-4Ala without the spike protein as well as when cells 252

were transfected with NRP1-WT plus SARS-CoV-2-S1 493-685 vs. NRP1-4Cys-4Ala plus SARS-253

CoV-2-S1 493-685 . Interestingly, the inclusion of SARS-CoV-2-S1 493-685 dramatically increased 254 differential expression of unique genes to 10 times higher between the two groups ( Fig. S3b) . 255

Collectively, these data potentially revealed previously unknown downstream targets involved in 256 NRP1 mediation of COVID-19 infections. 257 258

In this study, we report the discovery of novel cysteine residues residing in the extracellular domain 260 of NRP1 which, when mutated, interfere with its stability as well as its ability to bind with the 261 SARS-CoV-2 S protein. We demonstrated up to 4 times reduction in overall spike protein levels 262 even in the presence of an intact endogenous ACE2 receptor following mutation of these residues. 263

There was no significant association between the NRP1-4Cys-4Ala and SARS-CoV-2 variants, 264

suggesting that these novel cysteines are critical determinants for NRP1 activity. Moreover, NRP1 265 has been connected to the occurrence of various cancers. Interaction between NRP1 and its ligand, 266 VEGF165 known to cause pathological angiogenesis(52). Considered to be a therapeutic target 267 against cancer, NRP1 signaling could be modulated by targeting these novel cysteines since our 268 results showed cysteine-mutated NRP1 was unable to interact with its co-receptor Plexin-A1. In 269 conclusion, we provide a model where mutation of these cysteine residues in NRP1, especially the 270 first three located in two CUB and b1 domains, are sufficient to reduce SARS-CoV-2 spike protein 271 entry into cells (Fig.4d) . mutants together with different SARS-CoV-2 spike protein constructs as indicated for 30 hours, 296 followed by fixation in 4% paraformaldehyde. Next, the cells were permeabilized with 0.5% Triton 297 X-100 in PBS, washed and then blocked for 30 minutes at room temperature with 5% BSA in PBS. 298

Cells were incubated with primary antibodies in 5% BSA in 1X-PBS with 0.5% Triton X-100 for 299 1 hour at room temperature. After washing the cells were incubated with appropriate secondary 300 antibodies in 5% BSA in PBST for 30 minutes at room temperature. DNA was counterstained 301 with 1 µg/mL Hoechst 33342 and mounted with Fluorimount G (Southern Biotech). Cells were 302 imaged using a Zeiss LSM 710 confocal microscope. represented as mean ± SD, n = 3 (average 100 cells were observed for each condition per 563 experiment), and *p<0.05, **p < 0.005, *** p < 0.0005 were calculated by one-way ANOVA. Flag-SARS-CoV-2-S1 493-685

Flag-SARS-CoV-2-S1 493-685 :HA-NRP1 ratio HA-NRP1-4Cys-4Ala + + + +

Clinical features of 2019 novel coronavirus infection in Beijing

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 367 receptor

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit 44

PSMB7 is associated with anthracycline resistance and is a prognostic 456 biomarker in breast cancer

A DERL3-associated defect in the degradation of SLC2A1 mediates the 458 Warburg effect

Induction of Herpud1 expression by ER stress is regulated by Nrf1

Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L 463 (HSPA1L) Gene

Coronavirus infection, ER stress, apoptosis and innate immunity

ERO1-β, a pancreas-specific disulfide oxidase, 467 promotes insulin biogenesis and glucose homeostasis

Immunopathology of Hyperinflammation in COVID-19

NF-κB c-Rel Dictates the Inflammatory Threshold by Acting as a 471 Transcriptional Repressor

VEGF165 mediates formation of 473 complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding

HMMER web server: 2015 update

Relative Flag-SARS-CoV-2-S1